This case was reported by a consumer via call center representative and described the occurrence of burning hip in a 60-year-old male patient who received SHINGRIX for prophylaxis. On 26th September 2018, the patient received the 1st dose of SHINGRIX. On 28th September 2018, 2 days after receiving SHINGRIX, the patient experienced burning hip and pain in hip. On 29th September 2018, the patient experienced unable to walk. On 30th September 2018, the patient experienced tenosynovitis, white blood cell count high, bedridden and inflammation. On 25th October 2018, the patient experienced difficulty in standing and mobility decreased. On an unknown date, the patient experienced weight loss, stiffness, numbness in feet, tingling of extremity, stiffness hip, pain in spine and pain localized. The patient was treated with morphine, Opioids and prednisone. On 22nd October 2018, the outcome of the bedridden was recovered/resolved. On an unknown date, the outcome of the burning hip, tenosynovitis, weight loss, inflammation, stiffness hip, pain in spine, pain in hip and pain localized were unknown and the outcome of the unable to walk, difficulty in standing and mobility decreased were recovered/resolved and the outcome of the white blood cell count high, stiffness, numbness in feet and tingling of extremity were not recovered/not resolved. It was unknown if the reporter considered the burning hip, unable to walk, tenosynovitis, weight loss, white blood cell count high, bedridden, stiffness, difficulty in standing, mobility decreased, numbness in feet, tingling of extremity, inflammation, stiffness hip, pain in spine, pain in hip and pain localized to be related to SHINGRIX. Additional details were provided as follows: At approximately 4 to 5:00 PM, the patient received SHINGRIX on the right arm. The patient had a physical scheduled for that day and then it was suggested that he get the vaccine. The patient experienced severe burning pain in his hips. 3 days after receiving SHINGRIX, the patient was unable to walk. On 30th September 2018, the pain worsened and they had to carry him to his car and take him to the emergency room where they gave him morphine and opioids. 4 days after receiving SHINGRIX, the patient experienced Tenosynovitis in the hospital or inflammation but they were unsure because they had not seen anything like his experience before. They believed that the patient had a reaction to the vaccine. The patient had elevated high blood counts which were associated with internal inflammation. However, on 4th October 2018 on Thursday, his numbers came down. The patient was bed ridden for 22 days. Less than a week after receiving SHINGRIX, the patient lost 1/4 of his body weight initially, however, he had regained some of it back now. On 22nd October 2018, the patient received first injection of Prednisone in both hips. He could walk at the time of reporting, but he still had debilitating stiffness in his hips and spine. The patient had been off work for 7 weeks because he could not walk, stand or sit. The patient had three areas of pain initially which started in the left and right bursa and the back of his spine. The left and right bursa had cleared up but he still had pain from the waist. Less than a year after receiving SHINGRIX, the patient had numbness and tingling in his feet and lower legs which he could not recall when the pain started but it was still unresolved. On 25th October 2018, following on Thursday he had another Prednisone injection which cleared up the burse pain in his hips but he still has the stiffness. On 24th October 2018, the patient also went to the emergency room. The patient was very satisfied with the representative's attempts to help him. The patient was very frustrated with the fact that, he had terrible reaction to the vaccine. The patient was scheduled for some induction tests on Thursday with his healthcare professional. The patient was unable to work for going on seven weeks, he was still in a lot of pain, no resolution in sight. The reporter consented to follow.